Krishnan Kanna Palaniappan

Title: Krishnan Kanna Palaniappan: Innovator in Early Detection of Colon Disorders

Introduction

Krishnan Kanna Palaniappan is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of colon cell proliferative disorders. His work is crucial in advancing the understanding and treatment of colorectal cancer.

Latest Patents

Krishnan holds a patent for "Markers for the early detection of colon cell proliferative disorders." This patent encompasses systems, media, compositions, methods, and kits that relate to a panel of protein biomarkers. These biomarkers are essential for the early detection of colon cell proliferative disorders, including colorectal cancer. The presence or levels of these proteins in biological samples can be utilized for classifier generation and as inputs in machine learning models. This innovation is instrumental in classifying subjects in a population for the detection of colon cell proliferative disorders.

Career Highlights

Krishnan is currently employed at Freenome Holdings, Inc., where he continues to work on innovative solutions in the field of cancer detection. His expertise and dedication to research have positioned him as a key player in the medical technology landscape.

Collaborations

Some of his notable coworkers include Hayley Warsinske and Adam Drake. Their collaborative efforts contribute to the advancement of research and development in the field of early cancer detection.

Conclusion

Krishnan Kanna Palaniappan's work in developing biomarkers for the early detection of colon disorders represents a significant advancement in medical diagnostics. His contributions are vital for improving patient outcomes and enhancing the effectiveness of cancer detection methods.